Jump to main content
Jump to site search

Issue 6, 2017
Previous Article Next Article

Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4

Author affiliations

Abstract

The replacement of acylamino by cyclic substituents in the position 4 of the pyrazolo[3,4-d]pyrimidine scaffold, led to highly active sigma-1 receptor (σ1R) ligands. Phenyl or pyrazolyl groups were the best in terms of affinity for the σ1R and the 4-(1-methylpyrazol-5-yl) derivative, 12f, was the most selective. Compound 12f is also one of the best σ1R ligands ever described in terms of lipophilic ligand efficiency, which translates into a good physicochemical and ADMET profile. In addition, 12f was identified as an antagonist of the σ1R in view of its potent antinociceptive profile in several pain models in mice.

Graphical abstract: Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4

Back to tab navigation

Supplementary files

Publication details

The article was received on 16 Feb 2017, accepted on 08 Apr 2017 and first published on 20 Apr 2017


Article type: Research Article
DOI: 10.1039/C7MD00078B
Citation: Med. Chem. Commun., 2017,8, 1246-1254
  •   Request permissions

    Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4

    J. L. Díaz, J. Corbera, D. Martínez, M. Bordas, C. Sicre, R. Pascual, M. J. Pretel, A. P. Marín, A. Montero, A. Dordal, I. Alvarez and C. Almansa, Med. Chem. Commun., 2017, 8, 1246
    DOI: 10.1039/C7MD00078B

Search articles by author

Spotlight

Advertisements